Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891554-02-000848
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d27929_sc13g.txt SC 13G 8425
  Complete submission text file 0000891554-02-000848.txt   10218
Mailing Address 9 PARKER IRVINE CA 92618
Business Address 9 PARKER IRVINE CA 92618 9494709011
NEXELL THERAPEUTICS INC (Subject) CIK: 0000864009 (see all company filings)

EIN.: 061192468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41947 | Film No.: 02549690
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ROYAL TRUST TOWERS DOMINION CENTRE 77 KING ST STE 3900 TORONTO A8 00000
ROYAL CANADIAN GROWTH FUND (Filed by) CIK: 0001055760 (see all company filings)